Skip to main content

Advertisement

Log in

Optimal decision criterion for detecting change in bone mineral density during serial monitoring: A Bayesian approach

  • Original Article
  • Published:
Osteoporosis International Aims and scope Submit manuscript

Abstract

Summary

Interpretation of change in serial bone densitometry using least significant change (LSC) may not lead to optimal decision making. Using the principles of Bayesian statistics and decision sciences, we developed the Optimal Decision Criterion (ODC) which resulted in 11–12.5% higher rate of correct classification compared with the LSC method.

Introduction

The interpretation of change in serial bone densitometry emphasizes using least significant change (LSC) to distinguish between true changes and measurement error.

Methods

Using the principles of Bayesian statistics and decision sciences, we developed the optimal decision criterion (ODC) based on maximizing a ‘utility’ function that rewards the correct and penalizes the incorrect classification of change. The relationship between LSC and ODC is demonstrated using a clinical sample from the Manitoba Bone Density Program.

Results

Under certain conditions, it can be shown that using LSC at the 95% confidence level implicitly equates the benefit of 39 true positive diagnoses with the harm of one false positive classification of BMD change. ODC resulted in an 11% higher rate of correct classification for lumbar spine BMD change and a 12.5% better performance for classifying total hip BMD change compared with LSC with this method.

Conclusions

ODC has the same clinical interpretation as LSC but with two major advantages: it can incorporate prior knowledge of the likely values of the true change and it can be fine-tuned based on the relative value placed on the correct and incorrect classifications. Bayesian statistics and decision sciences could potentially increase the yield of a BMD monitoring program.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1
Fig. 2

Similar content being viewed by others

References

  1. Cummings SR, Bates D, Black DM (2002) Clinical use of bone densitometry: scientific review. JAMA 288:1889–1897

    Article  PubMed  Google Scholar 

  2. Lewiecki EM, Watts NB, McClung MR et al (2004) Official positions of the international society for clinical densitometry. J Clin Endocrinol Metab 89:3651–3655

    Article  CAS  PubMed  Google Scholar 

  3. Lenchik L, Kiebzak GM, Blunt BA (2002) What is the role of serial bone mineral density measurements in patient management? J Clin Densitom 5(Suppl):S29–S38

    Article  PubMed  Google Scholar 

  4. Baim S, Wilson CR, Lewiecki EM et al (2005) Precision assessment and radiation safety for dual-energy X-ray absorptiometry: position paper of the International Society for Clinical Densitometry. J Clin Densitom 8:371–378

    Article  PubMed  Google Scholar 

  5. Bonnick SL, Johnston CC Jr, Kleerekoper M et al (2001) Importance of precision in bone density measurements. J Clin Densitom 4:105–110

    Article  CAS  PubMed  Google Scholar 

  6. Cummings SR, Palermo L, Browner W et al (2000) Monitoring osteoporosis therapy with bone densitometry: misleading changes and regression to the mean. Fracture Intervention Trial Research Group. JAMA 283:1318–1321

    Article  CAS  PubMed  Google Scholar 

  7. Sterne JA, Davey SG (2001) Sifting the evidence-what’s wrong with significance tests? BMJ 322:226–231

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  8. Lilford RJ, Braunholtz D (1996) The statistical basis of public policy: a paradigm shift is overdue. BMJ 313:603–607

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  9. Chesnut CH III, Rosen CJ (2001) Reconsidering the effects of antiresorptive therapies in reducing osteoporotic fracture. J Bone Miner Res 16:2163–2172

    Article  CAS  PubMed  Google Scholar 

  10. Gluer CC, Blake G, Lu Y et al (1995) Accurate assessment of precision errors: how to measure the reproducibility of bone densitometry techniques. Osteoporos Int 5:262–270

    Article  CAS  PubMed  Google Scholar 

  11. Nguyen TV, Pocock N, Eisman JA (2000) Interpretation of bone mineral density measurement and its change. J Clin Densitom 3:107–119

    Article  CAS  PubMed  Google Scholar 

  12. Pauker SG, Kassirer JP (1980) The threshold approach to clinical decision making. N Engl J Med 302:1109–1117

    Article  CAS  PubMed  Google Scholar 

  13. Leslie WD, Metge C (2003) Establishing a regional bone density program: lessons from the Manitoba experience. J Clin Densitom 6:275–282

    Article  PubMed  Google Scholar 

  14. Leslie WD, Caetano PA, MacWilliam LR et al (2005) Construction and validation of a population-based bone densitometry database. J Clin Densitom 8:25–30

    Article  PubMed  Google Scholar 

  15. Leslie WD (2006) The importance of spectrum bias on bone density monitoring in clinical practice. Bone 39:361–368

    Article  PubMed  Google Scholar 

  16. Weiss NA (eds) (2005) A Course in Probability. Addison-Wesley

  17. Van DS (2006) Prior specification in Bayesian statistics: three cautionary tales. J Theor Biol 242:90–100

    Article  Google Scholar 

  18. Tversky A, Kahneman D (1974) Judgment under Uncertainty: Heuristics and Biases. Science 185:1124–1131

    Article  CAS  PubMed  Google Scholar 

  19. Karpf DB, Shapiro DR, Seeman E et al (1997) Prevention of nonvertebral fractures by alendronate. A meta-analysis. Alendronate Osteoporosis Treatment Study Groups. JAMA 277:1159–1164

    Article  CAS  PubMed  Google Scholar 

  20. Nguyen TV, Sambrook PN, Eisman JA (1997) Sources of variability in bone mineral density measurements: implications for study design and analysis of bone loss1. J Bone Miner Res 12:124–135

    Article  CAS  PubMed  Google Scholar 

  21. Jones G, Nguyen T, Sambrook P et al (1994) Progressive loss of bone in the femoral neck in elderly people: longitudinal findings from the Dubbo osteoporosis epidemiology study. BMJ 309:691–695

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  22. Hoch JS, Briggs AH, Willan AR (2002) Something old, something new, something borrowed, something blue: a framework for the marriage of health econometrics and cost-effectiveness analysis. Health Econ 11:415–430

    Article  PubMed  Google Scholar 

  23. Dalkey N, Helmer O (1963) An experimental application of the Delphi method to the use of experts. Manage Sci 9:458–467

    Article  Google Scholar 

  24. Patel JK, Read CB (eds) (1982) Handbook of the normal distribution. New York, Dekker, M

Download references

Acknowledgments

This article has been reviewed and approved by the members of the Manitoba Bone Density Program Committee. The author and committee would like to express their gratitude to Manitoba Health, the Winnipeg Regional Health Authority and the Brandon Regional Health Authority for their vision, trust and support in the establishment of this Program.

Funding

none

Conflicts of interest

None

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to W. D. Leslie.

Appendix

Appendix

Appendix 1. Calculation of the probability of TP, TN, FP, and FN

Using the notations describes in the text and the general assumptions of our approach (see Methods), we have

$$\begin{array}{*{20}l}{x \sim N\left( {\mu _x ,\sigma _x } \right)} \hfill \\{\left. y \right|x \sim N\left( {x,\sigma _p } \right)} \hfill \\\end{array} $$

Based on the properties of the normal distribution [24], and that e and x are assumed independent, the joint distribution of the x and y is a bivariate normal:

$$\left[ {\begin{array}{*{20}l}x \hfill \\{} \hfill \\y \hfill \\\end{array} } \right] \sim BVN\left( {\left[ {\begin{array}{*{20}l}{\mu _x } \hfill \\{} \hfill \\{\mu _x } \hfill \\\end{array} } \right],\left[ {\begin{array}{*{20}l}{\sigma _x^2 \quad \quad \sigma _x^2 } \hfill \\{\sigma _x^2 \quad \sigma _x^2 + \sigma _p^2 } \hfill \\\end{array} } \right]} \right)$$

The first and second parameters are the mean and covariance matrix of the bivariate normal distribution, respectively. The probability that a subject falls into each category can, therefore, be calculated using the cumulative distribution function of the bivariate normal distribution from the above equation. Defining the function Ф(a,b,ρ) as the cumulative distribution function of the standard bivariate normal distribution with at point (a, b) with correlation function ρ, we will have:

$$\begin{array}{*{20}l}{P_{TP} = \Phi \left( {\frac{{x - T_x }}{{\sigma _x }},\frac{{y - T_y }}{{\sqrt {\sigma _x^2 + \sigma _y^2 } }},\frac{{\sigma _x }}{{\sqrt {\sigma _x^2 + \sigma _y^2 } }}} \right)} \hfill \\{P_{FP} = \Phi \left( {\frac{{x - T_x }}{{\sigma _x }},\frac{{T_y - y}}{{\sqrt {\sigma _x^2 + \sigma _y^2 } }},\frac{{\sigma _x }}{{\sqrt {\sigma _x^2 + \sigma _y^2 } }}} \right)} \hfill \\{P_{TN} = \Phi \left( {\frac{{T_x - x}}{{\sigma _x }},\frac{{T_y - y}}{{\sqrt {\sigma _x ^2 + \sigma _y ^2 } }},\frac{{\sigma _x }}{{\sqrt {\sigma _x ^2 + \sigma _y ^2 } }}} \right)} \hfill \\{P_{FN} = \Phi \left( {\frac{{T_x - x}}{{\sigma _x }},\frac{{y - T_y }}{{\sqrt {\sigma _x^2 + \sigma _y^2 } }},\frac{{\sigma _x }}{{\sqrt {\sigma _x^2 + \sigma _y^2 } }}} \right)} \hfill \\\end{array} $$

Appendix 2. Derivation of ODC

One way to derive ODC is to solve the derivate of the utility function in Eq. 4 for T x . However, an easier way is to consider the utility of a decision based on observing change Y

$$U = \left\{ {\begin{array}{*{20}l}{Y <T_y \quad z.S_{TP} + \left( {1 - z} \right)S_{FP} \quad \left( {{\text{change}}\;{\text{detected}}} \right)} \hfill \\{Y >T_y \quad z.S_{FN} + \left( {1 - z} \right)S_{TN} \quad \left( {{\text{no}}\;{\text{change}}\;{\text{detected}}} \right)} \hfill \\\end{array} } \right.$$

while from Eq. 2:

$$z = Z\left( {\frac{{T_x - \frac{{\sigma _p^2 \mu _x + \sigma _x^2 Y}}{{\sigma _x^2 + \sigma _p^2 }}}}{{\sqrt {\frac{{\sigma _p^2 \sigma _x^2 }}{{\sigma _x^2 + \sigma _p^2 }}} }}} \right)$$

The goal is to find T y that results in the selection of the maximum of the two terms in U for all Y. This would be achieved by matching T y to a Y for which the utilities for positive and negative classification are equal. For any Y below this critical value, our policy would detect an unfavorable change and the utility of our decision equals the first term, which is also the maximum of the two for the same Y given the fact it is a descending function of Y as long as S TP  > S FP and S TN  > S FN . Setting the two terms equal and solving for Y, we will have:

$$z.S_{TP} + \left( {1 - z} \right)S_{FP} = z.S_{FN} + \left( {1 - z} \right)S_{TN} \Rightarrow z = \frac{{S_{TN} - S_{FP} }}{{S_{TN} - S_{FP} + S_{TP} - S_{FN} }}$$

Solving for Y yields Eq. 6 for ODC.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Sadatsafavi, M., Moayyeri, A., Wang, L. et al. Optimal decision criterion for detecting change in bone mineral density during serial monitoring: A Bayesian approach. Osteoporos Int 19, 1589–1596 (2008). https://doi.org/10.1007/s00198-008-0615-1

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00198-008-0615-1

Keywords

Navigation